185 related articles for article (PubMed ID: 37682177)
1. Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis.
Al Sharie AH; Abu Zahra AM; El-Elimat T; Darweesh RF; Al-Khaldi AK; Abu Mousa BM; Amer MSB; Al Zu'bi YO; Al-Kammash K; Abu Lil A; Al Malkawi AA; Alazzeh Z; Alali FQ
Medicine (Baltimore); 2023 Sep; 102(36):e35004. PubMed ID: 37682177
[TBL] [Abstract][Full Text] [Related]
2. Human pan-cancer analysis of the predictive biomarker for the CDKN3.
Chen Y; Li D; Sha K; Zhang X; Liu T
Eur J Med Res; 2024 May; 29(1):272. PubMed ID: 38720365
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
4.
Al Sharie AH; Al Zu'bi YO; El-Elimat T; Al-Kammash K; Abu Lil A; Isawi IH; Al Sharie S; Abu Mousa BM; Al Malkawi AA; Alali FQ
J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836529
[No Abstract] [Full Text] [Related]
5. HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration.
Zhang F; Yuan D; Song J; Chen W; Wang W; Zhu G; Hu B; Chen X; Zhu J
Int Immunopharmacol; 2021 Oct; 99():107899. PubMed ID: 34217993
[TBL] [Abstract][Full Text] [Related]
6. CDKN3 expression is an independent prognostic factor and associated with advanced tumor stage in nasopharyngeal carcinoma.
Chang SL; Chen TJ; Lee YE; Lee SW; Lin LC; He HL
Int J Med Sci; 2018; 15(10):992-998. PubMed ID: 30013440
[No Abstract] [Full Text] [Related]
7. Upregulation of CCNB2 and a novel lncRNAs-related risk model predict prognosis in clear cell renal cell carcinoma.
Ren C; Wang Q; Xu Z; Pan Y; Wang S; Liu X
J Cancer Res Clin Oncol; 2024 Feb; 150(2):64. PubMed ID: 38300330
[TBL] [Abstract][Full Text] [Related]
8. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
[TBL] [Abstract][Full Text] [Related]
9. Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis.
Yang Z; Jiang Y; Wang L; Yu B; Cai H; Fan J; Zhang M
BMC Med Genomics; 2024 Feb; 17(1):60. PubMed ID: 38383432
[TBL] [Abstract][Full Text] [Related]
10. SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics.
Xu K; Wu Y; Chi H; Li Y; She Y; Yin X; Liu X; He B; Li X; Du H
Medicine (Baltimore); 2022 Sep; 101(37):e30270. PubMed ID: 36123895
[TBL] [Abstract][Full Text] [Related]
11. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
Cui Y; Zhou Z; Chai Y; Zhang Y
J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
[TBL] [Abstract][Full Text] [Related]
12. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
13. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
[TBL] [Abstract][Full Text] [Related]
15. Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma.
Guo H; Jiang S; Sun H; Shi B; Li Y; Zhou N; Zhang D; Guo H
Dis Markers; 2022; 2022():9443407. PubMed ID: 35299868
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
Zhou L; Liu S; Li X; Yin M; Li S; Long H
Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
[TBL] [Abstract][Full Text] [Related]
18. CDKN3 expression predicates poor prognosis and regulates adriamycin sensitivity in hepatocellular carcinoma
Dai W; Fang S; Cai G; Dai J; Lin G; Ye Q; Miao H; Chen M; Tan X; Chen N; Liu X; Li M
J Int Med Res; 2020 Jul; 48(7):300060520936879. PubMed ID: 32721244
[TBL] [Abstract][Full Text] [Related]
19. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
Li T; Xue H; Guo Y; Guo K
Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]